Table 2 Descriptive statistics of PIs
n (%) | p | ||
|---|---|---|---|
All admitted patients | 1186 | (100.0) | |
PI is(n = 203, %=100) | < 0.001† | ||
Community-acquired (CA) | 118 | (58.1) | |
Hospital-acquired (HA) | 74 | (36.5) | |
Community & hospital-acquired | 11 | (5.4) | |
PI prevalence [CI] | 17.6% | [11.3–23.8] | < 0.001† |
HAPI prevalence [CI] | 6.7% | [3.2–10.2] | 0.001† |
CAPI prevalence [CI] | 11.9% | [5.6–18.3] | < 0.001† |
Days till PI developed(n = 178, %=87.7) | < 0.001† | ||
Before/on admission | 115 | (64.6) | |
1–7 | 14 | (7.9) | |
8–30 | 23 | (12.9) | |
31–90 | 19 | (10.7) | |
91–180 | 3 | (1.7) | |
> 180 | 4 | (2.2) | |
Median [IQR] (for HAPI) | 18 | [8.0–50.0] | 0.553‡ |
PI duration(n = 178, %=87.7) | 0.003† | ||
0–7 | 24 | (13.5) | |
8–30 | 48 | (27.0) | |
31–90 | 43 | (24.2) | |
91–180 | 26 | (14.6) | |
181–365 | 21 | (11.8) | |
> 365 | 16 | (7.9) | |
Median [IQR] | 49 | [16.5–171.8] | < 0.001‡ |
PI is related to medical device(n = 203, %=100) | < 0.001† | ||
No | 180 | (88.7) | |
Yes | 23 | (11.3) | |
Worst-stage PI distribution(n = 200, %=98.5) | < 0.001† | ||
Stage 1 | 45 | (22.5) | |
Stage 2 | 88 | (44.0) | |
Stage 3 | 45 | (22.5) | |
Stage 4 | 19 | (9.5) | |
Suspected deep tissue injury | 3 | (1.5) | |
Number of PI anatomic locations(n = 203, %=100) | 0.491† | ||
1 | 149 | (73.4) | |
2 | 36 | (17.7) | |
3 | 15 | (7.4) | |
4 | 2 | (1.0) | |
7 | 1 | (0.5) | |
Median [IQR] | 1 | [1.0–2.0] | 0.244‡ |
PI anatomic site distribution1 | |||
Sacrum | 168 | (82.8) | 0.287† |
Buttocks | 28 | (13.8) | 0.253† |
Heels | 27 | (13.3) | 0.026† |
Back | 24 | (11.8) | 0.640† |
Thigh | 7 | (3.4) | 0.799† |
Lower limbs | 7 | (3.4) | 0.883† |
Hips | 6 | (3.0) | 0.397† |
Elbow | 5 | (2.5) | 0.796† |
Back of head | 3 | (1.5) | 0.358† |
Anal region | 1 | (0.5) | 0.902† |
Other sites | 5 | (2.5) | 0.194† |